A Phase 3 Open-label, Multicenter Study to Evaluate the

Project: Research project

Project Details

Description

A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861 (Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients
StatusActive
Effective start/end date2/8/183/28/22

Funding

  • LIQUIDIA TECHNOLOGIES, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.